To study the mechanisms of John Cunningham virus (JCV) infection causing progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab
Latest Information Update: 22 Nov 2016
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 22 Nov 2016 New trial record